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Abstract
Introduction:Concern exists that radiation exposure from computerized tomography (CT)
will cause thousands ofmalignancies. Other experts share the same perspective regarding the
risk from additional sources of low-dose ionizing radiation, such as the releases from Three
Mile Island (1979; Pennsylvania USA) and Fukushima (2011; Okuma, Fukushima
Prefecture, Japan) nuclear power plant disasters. If this premise is false, the fear of cancer
leading patients and physicians to avoid CT scans and disaster responders to initiate forced
evacuations is unfounded.
Study Objective: This investigation provides a quantitative evaluation of the methodologic
quality of studies to determine the evidentiary strength supporting or refuting a causal rela-
tionship between low-dose radiation and cancer. It will assess the number of higher quality
studies that support or question the role of low-dose radiation in oncogenesis.
Methods:This investigation is a systematic, methodologic review of articles published from
1975–2017 examining cancer risk from external low-dose x-ray and gamma radiation,
defined as less than 200 millisievert (mSv). Following the PRISMA guidelines, the authors
performed a search of the PubMed, Cochrane, Scopus, and Web of Science databases.
Methodologies of selected articles were scored using the Newcastle Ottawa Scale (NOS)
and a tool identifying 11 lower quality indicators. Manuscript methodologies were ranked
as higher quality if they scored no lower than seven out of nine on theNOS and contained no
more than two lower quality indicators. Investigators then characterized articles as support-
ing or not supporting a causal relationship between low-dose radiation and cancer.
Results: Investigators identified 4,382 articles for initial review. A total of 62 articles met all
inclusion/exclusion criteria and were evaluated in this study. Quantitative evaluation of the
manuscripts’ methodologic strengths found 25 studies met higher quality criteria while 37
studies met lower quality criteria. Of the 25 studies with higher quality methods, 21 out of 25
did not support cancer induction by low-dose radiation (P= .0003).
Conclusions: A clear preponderance of articles with higher quality methods found no
increased risk of cancer from low-dose radiation. The evidence suggests that exposure to
multiple CT scans and other sources of low-dose radiation with a cumulative dose up to
100 mSv (approximately 10 scans), and possibly as high as 200 mSv (approximately 20
scans), does not increase cancer risk.
Schultz CH, Fairley R, Murphy LSL, Doss M. The risk of cancer from CT scans and
other sources of low-dose radiation: a critical appraisal of methodologic quality.
Prehosp Disaster Med. 2020;35(1):3–16.
Introduction
Background
There is little doubt that the advent of computerized tomography (CT) and other diag-
nostic radiologic imaging has revolutionized the practice of medicine; CT scans have
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essentially become ubiquitous in the United States, where approx-
imately 74 million scans were performed in 2017.1 While this
imaging technique offers benefits, the potential cancer risk asso-
ciated with these studies remains controversial. If the wide-spread
use of this technology is really inducing thousands of future cancer
deaths, as suggested by Brenner, Berrington de Gonzalez, Smith-
Bindman, and others, then the restrictive clinical guidelines being
recommended by multiple organizations would be justified to
protect the general population.2–4 However, if the risk is inaccur-
ately represented, then the mandate to reduce CT scanning
regardless of indication may not be rational. It is imperative that
clinicians, as well as the public, understand the risks and benefits
of diagnostic studies used in everyday practice. Therefore, an
objective analysis of the evidence to date is necessary to evaluate
the risk of cancer from CT scans.
To help understand the approach used in the following inves-
tigation, some background information is needed. For general
purposes, when quantifying radiation exposure, the units of
measure used are the Sievert (Sv) and Gray (Gy). The Sv quan-
tifies the amount of damage done to the human body while the Gy
is the energy absorbed in the body per unit mass. For both x-rays
and gamma rays, the two units of measure are numerically equiv-
alent (ie, one Gy of radiation dose causes one Sv of damage). In
addition, both gamma rays and x-rays are thought to behave the
same within human tissue, causing equivalent injury. Therefore,
cancer studies involving either entity apply to both. The dose from
a single CT scan ranges from two millisieverts (mSv) to 20 mSv,
with an average of two mSv per head CT and 10 mSv per CT scan
of the abdomen and pelvis. As a comparison, most Americans
receive three mSv per year from natural background radiation
sources.5
The most important study in estimating the cancer risk
from radiation exposure is the continuous long-term follow-up
investigation of Japanese survivors from the atomic bombs
dropped on Hiroshima and Nagasaki in 1945. This longitudinal
study is known as the Life Span Study, or LSS. In this Japanese
population, cancer mortality and incidence have been studied as a
function of radiation dose. Periodic reports on the data from this
study are published by the Radiation Effects Research
Foundation (Hiroshima, Japan).6 The health effects of radiation
have been reviewed and published periodically by the Biological
Effects of Ionizing Radiation Committee, or BEIR, of the
National Academy of Sciences (Washington, DC USA), with
the latest iteration of the report being BIER VII in 2006.7
Since the first assessments of cancers in LSS participants,
the analyses have reported a linear relationship between cancer
incidence/mortality and increasing radiation dose when examining
exposures of approximately one Gy and above. A report published
in 2012 analyzing LSS data from 1950–2003 used a linear quad-
ratic approach but asserts a similar overall relationship.8 However, a
separate evaluation focused on the cancer risk at lower doses that
did not rely on the linear model, especially at 200 milligray
(mGy) and below, was not performed.
Due to the observed linear relationship at higher doses, and
the potential for large errors in estimating excess cancer risk at
low-doses, the authors of the serial BEIR Committee reports have
extrapolated the observed linear relationship between radiation
dose and excess cancers to apply to all doses. This approach has
led to the linear-no-threshold (LNT) model relating cancer risk
to exposure, illustrated in Figure 1. While this figure is derived
from earlier data, it depicts the concept. The theory states that
any amount of radiation increases cancer risk and no safe level of
exposure exists. In other words, no threshold exists below which
radiation exposure does not cause cancer. This concept of a
linear relationship between cancer risk and radiation dose across
all exposure levels has essentially been used for estimations of
health risks from radiation for the last 60 years. Calculations of
cancers caused by radiation exposure and safety limits for exposed
populations were all derived from the LNT model.
Importance
For the first few decades after the model was proposed, little reason
existed to challenge it. Only a minute segment of the population
was at-risk for significant radiation exposure. All this changed with
the invention of the CT scan in 1972, and the exponential rise in its
utilization since. Now, very large segments of the population are
receiving higher radiation exposures, and the potential risk of
cancer in the dose range of 100–200 mSv has become a very
important issue. Recent publications have reached conflicting
conclusions with respect to the cancer risk from low-dose exposure,
resulting in intense debate regarding the validity of the LNT
model.8,9 As such, the presence or absence of a threshold exposure
limit for radiation-induced cancer has become a critical issue for the
medical community and the public. Significant effort and progress
have been made by the medical community to reduce radiation
exposure, as documented by the National Council on Radiation
Protection 160 (Bethesda, Maryland USA) and benchmarks such
as the American College of Radiology’s (Reston, Virginia USA)
CT Dose Registry.
The latest analysis of the LSS data published by Grant, et al in
2017 only fuels the debate. Investigators demonstrated a threshold
for cancer risk in men below 100 mGy.9 However, the authors
were unable to make firm conclusions stating: “Findings from
the current analysis regarding the dose-response shape were not
fully consistent with those previously reported, raising unresolved
Schultz © 2020 Prehospital and Disaster Medicine
Figure 1. Linear-No-Threshold (LNT) Model.
Note: Relationship between increased cancer risk and radiation
dose as reported by the “Health Risks from Exposure to Low
Levels of Ionizing Radiation on: BEIR VII – Phase 2” report
with 90% confidence bars. (Graph created by Stephen David
Williams using the numbers reported in the BEIR report.
Used with permission.)
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questions. At this time, uncertainties in the shape of the dose
response preclude definitive conclusions to confidently guide
radiation protection policies.”9 Nonetheless, the authors supported
the use of a linear approach to data analysis consistent with the
LNT model.
It is difficult to digest the large amount of data available and the
conflicting conclusions stated in these publications. The authors
considered using a meta-analytic approach for evaluating study
outcomes but rejected it. All the investigations of human low-dose
radiation exposure in the world’s literature involve only cohort or
case control studies. No prospective randomized trials exist.
Cohort and case control studies are considered less robust designs,
making meta-analysis of their results of questionable value. While
some cohort and case control studies follow appropriate design
rules, many are poorly constructed and highly flawed. As such,
applying meta-analytic techniques to this mixture will yield results
heavily confounded by lack of controls, poor study design, and
flawed statistical evaluations. The resulting odds ratios and confi-
dence intervals would have, at best, weak validity and at worst, be
completely meaningless. In addition, the value of combining such
studies is questionable. Given many involve different populations,
outcome measures, sources of radiation, duration of exposure,
sample size, and length of follow-up, the measurement of their
heterogeneity would be very high, further compromising the
validity of any findings.
It might be possible, however, to approximate an answer by
identifying all the case control and cohort studies that more
rigorously adhere to sound methodological design (utilize higher
quality methodologies) and determine the number that either
support or do not support the hypothesis that low-dose radiation
causes cancer. A large preponderance of such investigations that
endorse one or the other perspective would provide useful
guidance.
Study Objective
Toward this end, the authors proposed examining the methodo-
logic quality of investigations evaluating low-dose radiation and
cancer induction published from 1975 through 2017. The articles’
methodologies are scored using two separate tools to create a
quantitative assessment measuring the strength of study design
and identifying higher quality investigations. This will permit
direct comparison between the number of studies using higher
quality methodologies supporting cancer induction by low-dose
radiation, and those refuting it, allowing assessment of the risks
of cancer from low-dose radiation.
Methods
Study Design and Article Selection
Following the PRISMA guidelines, a systematic search was
conducted in MEDLINE/PubMed (US National Library of
Medicine, National Institutes of Health; Bethesda, Maryland
USA); Scopus (Elsevier; Amsterdam, Netherlands; which includes
coverage of EMBASE); Web of Science (Thomson Reuters; New
York, New York USA); and the Cochrane Library (The Cochrane
Collaboration; London, United Kingdom) for studies published in
English from January 1975 through October 2017 evaluating the
risk of cancer from low-dose radiation. The authors began the
review in 1975 to allow sufficient time after the 1972 invention
of the CT scan for research publications to appear that might
include the device. A professional health sciences librarian (LM)
designed and conducted the initial search on PubMed, and then
applied the search strategy (Appendix A; available online only)
to subsequent selected databases. All search results were imported
into EndNote (Clarivate Analytics; Philadelphia, Pennsylvania
USA), wherein duplicate studies were removed. For the search
string, low-dose was defined as less than 200 mSv for the purposes
of article inclusion. The current definition of low-dose is up to
100 mSv; however, the authors wanted to ensure identification
of all potential studies.10 In addition, articles investigating low-
dose radiation were not restricted to diagnostic medical devices.
Analyses of low-dose gamma radiation, such as studies examining
cancer rates in nuclear power industry workers or those exposed to
elevated levels of background radiation, were included. Other
publications from government and regulatory agencies were added
as well, as those identified from selected article bibliography
reviews conducted manually by the authors.
Eligibility Criteria for Inclusion
To be included in the study, articles had to address the potential
role or impact of low-dose gamma or x-ray radiation on the risk
of developing any type of cancer. A list of article inclusion and
exclusion criteria are contained in Table 1. First, two reviewers
(CHS and RF) independently screened the titles and abstracts
based on the criteria in Table 1. If this evaluation suggested the
publications were potentially eligible for inclusion, the same
reviewers examined the full-texts to make a final determination.
INCLUSION CRITERIA
Adults and children
Low-dose radiation defined as 200 mSv or less
Studies published from 1975 through 2017
English language
Randomized controlled trials (andmeta-analysis), cohort studies, case
control studies
External x-ray or gamma radiation exposure from diagnostic,
environmental (including atomic bomb Survivors), or occupational
sources
Studies where radiation exposure is either measured directly
or estimated using current equipment and accepted methods
where number and type of exposures are documented in a verifiable
dataset
EXCLUSION CRITERIA
Animal studies
High-dose exposures, to include therapeutic radiation
Prenatal and preconception exposures
Articles addressing radiation effects on cells (adaptive response and
bystander effects), chromosomes, biochemistry, or other non-
organism targets
Review articles, abstracts, or editorials
Articlesmeasuring calculatedor estimated cancers basedonmodeling
of exposure risk
Substantial exposure from internal contamination (excluding radon)
Studies of patients with previous history of cancer
Studies examining radiation impact on other diseases besides
cancer such as meningiomas, cardiovascular disease, or mental
health
Studies using surveys/questionnaires, number of procedures
performed, or other indirect markers for actual radiation exposure
Schultz © 2020 Prehospital and Disaster Medicine
Table 1. Article Inclusion and Exclusion Criteria
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If the two reviewers disagreed regarding study eligibility,
differences of opinion were resolved by consensus. Any persistent
disagreement was resolved by a third independent reviewer (MD).
For datasets with multiple publications that serially evaluated the
same population over time, only the most recent publication was
considered for inclusion in the study.
Measurements or Key Outcomes
After identifying the final set of articles, the methodology of each
paper was independently scored by two reviewers (CHS and RF)
using two separate tools to determine the quality of the research
approach. Reviewers used a scoring template to reduce inconsis-
tency. The first tool is the Newcastle Ottawa Scale (NOS) initially
created by George Wells, PhD.11 In an extensive review of
approaches used for evaluation of non-randomized studies, 194
tools were identified that could be or had been used to assess such
trials. Of these, only six were found to be suitable for systematic
reviews, with the NOS being one.12 The NOS was chosen as it
is specifically designed to evaluate the methodologies of cohort
and case control studies, has been in use for over 15 years, and is
frequently referenced in the emergency medicine literature. It
scores articles on a range of zero to nine based on evaluations in
three categories: (1) Selection of cases/controls or cohorts; (2)
Comparability of case/controls or cohorts based on design; and
(3) Exposure or Outcome (Appendix B; available online only).
Articles with scores of seven or greater were considered higher
quality, given that most authors using the NOS identify this
number as the lower limit characterizing good studies. However,
the NOS does not evaluate all methodological aspects. To capture
potential weaknesses the NOS misses, a second tool is required to
fully characterize the studies by examining data analysis. This
tool was developed by the authors and adapted from established
resources in research methodology (ie, statistics texts and review
articles). It identifies 11 lower quality indicators that are used to
score the studies. Examples of these indicators include use of
90% confidence intervals, one-tailed T tests, failure to address
confounding variables or predisposing factors, and no adjustment
for multiple comparisons (Appendix C; available online only). An
article found to contain two or fewer indicators is considered higher
quality, mirroring the NOS that allows a reduction of up to two
points for higher quality methodologies. An article’s methodology
was considered higher quality if: (1) it scored seven or more on the
NOS, and (2) it contained two or fewer lower quality indicators.
Failure to meet both metrics resulted in a study’s methodology
evaluated as lower quality. After independent scoring of all articles,
both reviewers compared their results to reach consensus.
For meta-analytic studies, the NOS is not appropriate.
To score these investigations, the authors used the Quality
Assessment of Systematic Reviews andMeta-Analyses developed
by the National Institute of Health’s (Bethesda, Maryland USA)
National Heart, Lung, and Blood Institute. This tool evaluates
eight criteria as present or absent and yields a rating of good, fair,
or poor.13 Articles containing a minimum of six criteria were
considered higher quality, to maintain consistency with the
other scoring tools. The lower quality indicator tool was applied
to these studies without modification. Only one article required
assessment using this tool.
Data Analysis
The articles were then divided into two groups: those supporting
the risk of cancer from low-dose radiation, and those that did
not. Investigators determined the support status by examining
the conclusion section of the abstract, and when necessary, the
conclusion section in the manuscript. The conclusion had to state
or imply that all doses of radiation were associated with increased
cancer risk. In some studies, the data reported in the results
potentially contradicted the authors’ conclusions. For the purposes
of this investigation, however, the authors’ statements were used to
characterize the article. This same approach was used for studies
that found an increase in some cancers but not others. Articles
identified as not supporting the risk of cancer had to demonstrate
a threshold for cancer induction at some level up to and includ-
ing100–200 mSv, and that increased cancer rates were not observed
or existed only above the threshold value. Finally, the number
of higher quality articles supporting or not supporting cancer
induction by low-dose radiation was counted, and the difference
between the two groups was evaluated using a chi-squared test
for independence (Stata, Statacorp; College Station, Texas
USA) with a P value of less than .05 considered significant.
Since the study involved only de-identified data, the research team
was not required to obtain Institutional Review Board approval.
Results
Characteristics of Selected Articles
The literature search identified 4,382 potential articles for
consideration: 4,361 retrieved from electronic databases and 21
obtained from bibliography reviews. After removal of duplicates,
3,578 publications remained. Initial screening of titles and
abstracts reduced the number of articles further to 237.
Detailed, independent full-text review of these remaining publica-
tions resulted in identification of 62 articles for inclusion in the
study. Consensus was reached on all articles except one, which
required intervention by a third author to adjudicate its disposition.
A detailed graphic representation of the process following the
PRISMA guidelines is listed in Figure 2.
Main Results
After evaluating and scoring the methodologic quality of all
62 articles, researchers identified 25 articles as utilizing higher
quality approaches (Table 29,14–37) and 37 characterized by lower
quality approaches (Table 338–74). These were fairly evenly divided
with 27 articles endorsing cancer induction by low-dose radiation
and 35 rejecting it. Examining the 25 higher quality methodology
publications, the authors found 21 did not support the risk of
cancer from low-dose radiation and four supported it. Using a
chi-squared test for independence, this finding was significant with
P= .0003. The only publications to receive perfect scores on the
two methodologic evaluations both did not support cancer risk.
For investigations using lower quality methodologies, 23 supported
cancer induction while 14 rejected it. Details of the scoring
evaluation for each article are found in Appendix D (available
online only).
Discussion
The initial possibility that radiation might increase mutations, and
subsequently the risk of cancer, was raised by the work of HJ
Muller, published in 1927.75 He demonstrated a linear increase
in fruit fly mutations with exposure to rising doses of x-rays, but
used only high doses with the lowest dose being four Gy. A later
study performed by Spencer during theManhattan Project showed
a similar linear relationship of mutations to radiation dose for
short-duration exposures, but did not expose the fruit flies to
low-dose radiation, stopping at a dose of 250 mGy.76 The influence
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of the Spencer investigation, in combination with the advocacy by
Muller and others, resulted in the formal acceptance of the LNT
model (all radiation causes cancer and the risk increases as a linear
function of increasing radiation dose) by the National Academy of
Sciences Genetics Panel on the Biological Effects of Atomic
Radiation (BEAR I Committee, later to become the BEIR
Committee) in 1956.77
This linear model has remained the pivotal explanation for the
relationship between radiation and cancer. The entire premise
behind articles such as the one by Brenner, et al and others, that
CT scans are causing cancer, is based on this model.2,3 If this model
is false, however, his estimate that possibly as many as 1.5% to 2.0%
of all cancers in the United States are caused by CT scans would be
wrong. The purpose of this study was to examine the methodologic
strengths of the literature and determine if the evidence from
investigations using higher quality case control and cohort study
methodologies supports or does not support the risk of cancer from
low-dose radiation.
Researchers identified only four out of 25 studies characterized
by higher quality methodologies that endorsed a risk of cancer from
low-dose radiation. While no standard exists that can absolutely
indicate when a sufficient quantity of higher quality studies
has been performed to change practice, one can consider a change
if the clear preponderance of these studies suggests a new
direction is indicated. In this analysis, 21 out of 25 investigations
characterized as using higher quality methodologies demonstrated
the existence of a threshold for cancer induction. These studies
demonstrated no increased cancer risk for individuals experiencing
radiation exposures up to at least 100 mGy, and possibly as high as
200 mGy.
The authors acknowledge that attempting a quantitative
analysis of methodologic quality will incorporate a certain amount
of subjectivity. No tool currently available can completely eliminate
this risk. However, significant guidance on use of the NOS exists,
including structured scoring tools that can increase consistency in
evaluations. These data collection sheets were employed through-
out the entire evaluation (Appendix E; available online only). In
addition, the use of the lower quality indicator tool to supplement
the NOS provides a method of evaluation that is less subject to
interpretation and more objective. This second evaluation tool is
needed because the NOS does not evaluate how data are analyzed.
Even if a study received a perfect score on the NOS, it can still have
significant weaknesses in the way data are evaluated. Common
errors such as use of 90% confidence intervals (CIs), failure to
control for reverse causation, and failure to adjust for significant
predisposing factors beyond the two that are addressed in the
NOS all can result in lower quality methodologic approaches.
These are the types of indicators used to create the second tool.
Schultz © 2020 Prehospital and Disaster Medicine
Figure 2. PRISMA Flow Diagram of Study Selection.
Note: Chart depicting the process of reviewing and selecting eligible articles from literature search for subsequent methodologic
scoring. (From: DOI: 10.1371/journal.pmed.1000097.)
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To improve transparency, the individual scores for all articles are
included in Appendix D (available online only), so readers can
assess the study methodology evaluations for themselves.
Evaluation tools such as Grades of Recommendation,
Assessment, Development, and Evaluation and others were not
used for this study. They lack sufficient granularity to address
the wide-range of study designs and subjects involved. As essen-
tially none of the articles reviewed were randomized, controlled,
prospective studies, they all would receive lower marks. This makes
discrimination between cohort and case control studies using
higher and lower quality methodologies difficult. Given all but
one included article was either a case control or cohort study, inves-
tigators needed evaluations tools that would be effective in scoring
these papers. That is why researchers selected the NOS and Lower
Quality Indicator Scale.
The most widely cited data supporting the hypothesis that all
radiation causes cancer comes from analysis of the LSS. While
the data collected in this study are accurate, the linear and linear
quadratic interpretation of the relationship between radiation
and cancer across all levels of exposure is potentially flawed. In
the latest examination of the LSS data by Grant, et al, a linear
or curvilinear relationship does exist between increasing doses
of radiation and an increased risk of cancer starting above
200 mGy.9 However, as one moves down the graphic line to lower
doses of radiation below 200 mGy, a clear risk of increased cancer
induction disappears. The graphs depicting the relationship
between absorbed dose and cancer risk illustrate this observation
(Figure 3). The dashed line illustrating the lower bounds of the
95% confidence interval for excess relative risk for cancer in men
remains below zero until past 200 mGy, while that for women
does not become positive until past 100 mGy.9 This fairly clearly
suggests the possibility of a threshold for cancer risk if these data
were evaluated as a separate entity rather than in totality with all the
other data. Indeed, the conclusion of this latest LSS study shows
no increased cancer risk in men for doses up to 100 mGy (excess
relative risk of 0.010 with 95% confidence intervals of −0.0003
to 0.021).9
It appears possible that two separate phenomena occur across
the range of radiation exposure; one manifesting at low doses
(100 mSv, possibly extending to 200 mSv) and a second process
manifesting at higher doses. This is similar to the impact of
sunlight on the human body. Low doses of ultraviolent radiation
create vitamin D3 without causing significant skin damage.
High doses will cause sunburn and increase the risk of skin cancer.
Applying this concept, researchers would need a new objective
model that could depict both processes while making no assump-
tions about the data. In fact, such models exist. Doss, et al used a
regression approach in which the radiation dose in Gy was entered
into the model using a restricted cubic spline transformation with
four knots. This method of data analysis is flexible and allows the
line of best fit to cross the Y axis at any location and also allows for
negative predicted excess relative risk values. When this model is
applied to the data from a previous analysis of the LSS, the 95%
CIs for line of best fit are below zero for doses under 200 mGy,
clearly demonstrating the possibility of a threshold.78
Sasaki, et al, concerned about the same issue of constrained data
analysis, used a different approach. They employed an artificial
neural network to examine the relationship between radiation
dose and cancer risk. This method can identify changes in the
dose-response relationship and is not limited to one type of
graphical representation, allowing the line of best fit to follow
the data. Using this model, the authors also identified a threshold
effect, with no increased risk for radiation-induced cancer below
100–200 mSv.22
It might be useful to illustrate the difference found between
studies using higher quality and lower quality methodologies by
Figure 3. Cancer Risk for Males and Females as a Function of Increasing Radiation Exposure Up to 1 Gy.
Note: Panels A and B: Solid cancer dose-response functions for males and females (0–1 Gy). Fitted linear (black dashed line) and
linear-quadratic (black solid curve) ERRs for all solid cancers using linear and linear-quadratic dose-response functions for males
and females over the range of 0–1 Gy. Also shown are ERR estimates for 15 visible dose categories (points) and a nonparametric
smoothed estimate (solid grey curve) with point-wise 95%CIs (dashed grey curves). The ERRs are given for subjects at attained age
of 70 years after exposure at age 30 years. (Used with permission; copyright 2018 Radiation Research Society).
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describing several investigations involving the risk of cancer from
workplace radiation exposure from sources used to generate nuclear
power. Studies concluding no cancer threshold exists suffer from
significant flaws, including the use of spurious data, 90% confi-
dence intervals, one-tailed tests of significance, and outcome mea-
sures that obscure the presence of a low-dose threshold, such as
increased cancer risk per Gy or use of a restricted linear approach
for data representation.43,44,55,79 Re-analysis of a study using
information on occupational radiation exposure in the nuclear
power industry from 15 countries that initially found a significant
increase in cancer risk from low-dose exposure found no signifi-
cantly increased risk after spurious Canadian data were excluded.21
In contrast, the Johns Hopkins School of Public Health
(Baltimore, Maryland USA) conducted a study of cancer incidence
in nuclear shipyard workers. This investigation was a rigorously
performed search for health risks of radiation to civilian employees
of eight shipyards that overhauled and repaired nuclear-propelled
US Navy ships and submarines. They compared cancer rates
experienced by badged nuclear workers servicing nuclear powered
vessels who had exposure to low radiation doses with their
colleagues who did not enter the radiation areas and so were not
exposed to the low radiation doses. This eliminated any impact
from the “healthy worker effect” (the phenomenon that employed
individuals are healthier than the general population and so
comparisons between the two can lead to inaccurate results).
The authors used 95% confidence intervals and non-linear
restricted methods of data analysis, addressed such confounders
as socio-economic status, and stratified worker analysis by radiation
dose. These investigators found no increased risk of cancer from
exposure to low-dose radiation.33
Limitations
Several limitations exist that potentially impact the study results.
First, quantitative evaluation of methodologic quality incorporates
a certain degree of subjectivity. Some criteria are difficult to
objectively describe and so variability can occur in the quantifica-
tion process. Investigators minimized this by using a scoring
template that helped reduce inconsistency and by requiring
consensus for each score. Second, the study authors performed
the quantitative analysis.While it would be desirable to use another
group blinded to the study’s goal, it was not possible to find other
emergency physicians that were unbiased. All the physicians con-
tacted candidly admitted either a bias for or against the concept that
all radiation causes cancer. None honestly believed that a state of
equipoise could exist for either outcome. The authors were the only
emergency physicians identified that believed that both outcomes
were possible. Since scoring bias could not be completely elimi-
nated, the raw scores for all 62 articles are included in the appendix
so readers can assess the scoring accuracy for themselves. Third,
some studies, if only modestly-powered, may have failed to identify
a significant risk of cancer at lower doses due to the difference in the
effect size. If there was a significant, but small, association between
low-dose radiation and cancer, this might have required a larger
sample to detect than associations at higher doses, reflecting a
Type II error. However, this is unlikely as most studies included
participants in the tens of thousands. In addition, the LSS just
reported no evidence for cancer at doses below 100 mSv in men,
after reporting just the opposite for decades. This change reflects
results from a now adequately powered study. Fourth, some studies
may have yielded data that may not have easily fit within the binary
outcomes of “support” or “not support.”However, only three of the
62 articles produced mixed results, and none of these were in
the higher quality study group. Even for these investigations, the
authors’ conclusions easily placed them into one of the two catego-
ries. Fifth, the authors analyzed studies documenting chronic
exposure and acute intermittent exposure together. Very limited
data exist quantifying the difference between cumulative low-dose
exposure and single dose. Given the majority of studies evaluating
both exposure types found no increased cancer rates, this is less
likely to impact the results. Lastly, the lower quality indicator tool
has not been used previously. Nonetheless, all 11 criteria are
well-known, validated methodology flaws and are documented
in research design textbooks and multiple review articles. It would
seem difficult to argue that the results from studies with methods
containing three or more of these known flaws could produce a
meaningful evaluation.
Conclusion
This investigation demonstrates that a preponderance of studies
using higher quality case control and cohort methodology support
the existence of a threshold for cancer induction by radiation up to a
dose of 100 mSv, and possibly as high as 200 mSv. These findings
suggest that the cancer risk from this radiation dose is minimal and
exposure to at least 10 CT scans, and possibly as many as 20, is
unlikely to cause cancer.
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ARTICLES SUPPORTING CANCER INDUCTION BY LOW-DOSE RADIATION
Authors Year Total NOS
Score
Low-Quality
Indicator
Score
Sample Size Study Design Exposed Population Radiation Source Outcome Measures Follow-Up
Length
Grant EJ, Brenner A9 2017 8 2 80,205 Cohort Atomic bomb survivors Atomic bomb Solid cancers 51 years
De Gonzalez AB,
Salotti JA14
2016 7 2 178,602 Cohort Pediatric patients with
CT scans
CT scans Leukemia, malignant
brain lesion
23 years
Huang WY, Muo
CH15
2014 8 2 24,418 Cohort Pediatric patients with
head CTs
Head CT scans Malignant/benign brain
tumor
10 years
Daniels RD,
Bertke S16
2013 8 1 1,845 Nested case
control
US nuclear workers Radio-nuclides, nuclear
reactors
Leukemia mortality 54 years
ARTICLES NOT SUPPORTING CANCER INDUCTION BY LOW-DOSE RADIATION
Authors Year Total NOS
Score
Low-Quality
Indicator
Score
Sample Size Study Design Exposed Population Radiation Source Outcome Measures Follow-Up
Length
Kitahara CM, Linet
MS17
2017 8 2 110,297 Cohort US radiologic
technologist
Diagnostic medical
radiation
Death from brain/CNS
cancer
29 years
Krille L, Dreger S18 2015 8 1 44,584 Cohort Pediatric patients with
CT scans
CT scans Leukemia, lymphoma,
CNS tumor before age
15
15 years
Journy N,
Rehel J-L19
2015 8 0 67, 274 Cohort Pediatric patients with
CT scans
CT scans Cancer incidence before
age 15
10 years
Socol Y,
Dobrzyński L20
2015 8 1 86,661 Cohort Atomic bomb survivors Atomic bomb All cancer mortality 53 years
Zablotska LB, Lane
RSD21
2014 7 1 45,468 Cohort Canadian nuclear
workers
Radio-nuclides, nuclear
reactors
All cancer mortality 38 years
Sasaki MS,
Tachibana A22
2014 8 1 86,661 Cohort Atomic bomb survivors Atomic bomb Occurrence of all
cancers
50 years
Merzenich H,
Hammer GP23
2014 8 1 8,972 Cohort German nuclear power
workers
Nuclear power plants All cancer mortality 17 years
Cappa M,
Cambiaso P24
2013 7 1 123 Case control Patient < 18months old
with cardiac defects
Cardiac
catheter-ization
Thyroid abnormality and
cancer
24 years
Tao Z, Akiba S25 2012 7 2 31,604 Cohort Citizens living in
Yangjiang, China
Natural background
radiation
Cancer and
non-cancer deaths
20 years
Hammer GP,
Blettner M26
2012 7 1 6,000 Cohort Male German airline
pilots
Cosmic radiation Cancer mortality 44 years
Hammer GP,
Seidenbusch MC27
2011 9 0 78,527 Cohort German children under
age 14.5
Conventional radio-
graphic examination
Cancer incidence 26 years
Boice JD, Cohen S28 2011 9 2 46,970 Cohort Rocketdyne employees Nuclear reactors & fuel Mortality analysis 60 years
Jeong M, Jin YW29 2010 7 1 16,236 Cohort Male Korean nuclear
power workers
Nuclear power facilities Cancer incidence 14 years
12
C
ancer
Induction
by
C
T
Scans
and
O
ther
L
ow
-D
ose
Sources
P
rehospitaland
D
isaster
M
edicine
V
ol.35,N
o.1
https://doi.org/10.1017/S1049023X1900520X
D
ow
nloaded from
 https://w
w
w
.cam
bridge.org/core. N
ER PH
IA
, on 05 Feb 2020 at 19:55:07, subject to the C
am
bridge C
ore term
s of use, available at https://w
w
w
.cam
bridge.org/core/term
s.
Nair RRK, Rajan B30 2009 9 2 69,958 Cohort People living in
Karunagappally, India
Natural background
radiation
Cancer incidence 15 years
Gun RT, Parsons J31 2008 7 2 10,983 Cohort Male Australian
participants in nuclear
tests
Nuclear weapons tests Mortality and cancer
incidence
20 years
Yiin JH, Silver SR32 2007 7 1 4,388 Nested case
control
Portsmouth Naval
Shipyard workers
Nuclear powered ships
and x-rays
Lung cancer mortality 45 years
Sponsler R,
Cameron JR33
2005 9 0 70,730 Cohort US Nuclear shipyard
workers
Nuclear powered ships
and x-rays
All-cause and cancer
mortality
25 years
Howe GR, Zablotska
LB34
2004 9 1 53,698 Cohort US nuclear power
workers
US nuclear power plants Non-cancer and cancer
mortality
18 years
Inskip PD, Ekbom
A35
1995 8 2 968 Case control Swedish citizens getting
diagnostic medical
x-rays
Medical x- rays for
diagnosis
Thyroid cancer
incidence
58 years
Boice JD Jr,
Morin MM36
1991 7 2 2,481 Case control US members of 2
prepaid health plans
Medical x- rays for
diagnosis
Leukemia, NHL, multiple
myeloma
27 years
Storm HH,
Iversen E37
1986 7 2 479 Case control Tuberculosis patients in
Denmark
Chest fluoroscopy Breast cancer incidence 40 years
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Table 2. (continued). Articles with Higher Quality Methodologies Characterized by Supporting or Not Supporting Cancer Induction by Low-Dose Radiation
Abbreviations: CNS, Central Nervous System; CT, Computed Tomography; NHL, Non-Hodgkin’s Lymphoma; NOS, Newcastle Ottawa Scale; US, United States.
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ARTICLES SUPPORTING CANCER INDUCTION BY LOW-DOSE RADIATION
Authors Year Total NOS
Score
Low-Quality
Indicator
Score
Sample Size Study
Design
Exposed
Population
Radiation Source Outcome
Measures
Follow-Up
Length
Daniels RD,
Bertke SJ38
2017 7 3 308,297 Nested
Case-Control
Nuclear workers
(French, UK, US)
Radio-nuclides,
gamma ray, x-ray,
neutron
Mortality from
all solid
cancers,
leukemias
Average
27 years
Hsieh WH, Lin IF39 2017 7 4 6242 Cohort Taiwanese building
residents
Cobalt-60 (gamma
ray)
All cancer 30 years
Wang F, Sun Q40 2016 6 4 7703 Case Control Chinese medical
x-ray workers
Medical x-ray All cancer 315,309
Person- years
Preston DL,
Kitahara CM41
2016 8 3 66,915 Cohort US radiologic
technologists
Medical x-ray Breast cancer 1,089,502
person- years
Smoll NR, Brady Z42 2016 8 4 105,427 Cohort Atomic bomb
survivors
Atomic bomb
radiation
Brain cancer 40 years
Richardson DB,
Cardis E43
2015 7 4 308,297 Cohort Nuclear workers
(French, US, and
UK)
Radio-nuclides,
gamma ray, x-ray,
neutron
All cancer
mortality
8.2 million
person years,
median
26 years
Leuraud K,
Richardson DB44
2015 7 3 308,297 Cohort Nuclear workers
(French, US, and
UK)
Radio-nuclides,
gamma ray, x-ray,
neutron
Mortality from
leukemia and
lymphoma
8.22 million
person-years
Schubauer-Berigan
MK, Daniels RD45
2015 8 3 119,195 Cohort Nuclear workers
(US)
Radio-nuclides,
gamma ray, x-ray,
neutron
All cancer
mortality
4,019,065
person-years
Mathews JD,
Forsythe AV46
2013 6 2 680,211 Cohort Australian Medicare
patients
CT imaging All cancer Mean 9.5 years
Samartzis D,
Nishi N47
2013 8 3 80,180 Cohort Atomic bomb
survivors
Atomic bomb
radiation
Soft tissue
sarcoma
2,170,732
person-years
Choi KH, Ha M48 2013 7 4 36,394 Cohort Korean diagnostic
radiation workers
X-ray All cancer Max 7 years,
159,189
person-years
Eisenberg MJ,
Afilalo J49
2011 5 1 82,861 Cohort Canadian cardiac
patients
X-ray All cancer Mean 5 years
Ronckers CM,
Land CE50
2010 8 4 5,513 Cohort US Scoliosis female X-ray All cancer
mortality
Mean 47 years,
total 257,915
woman-years
Muirhead CR,
O’Hagan JA51
2009 8 4 174,541 Cohort UK Radiation
workers
Radio-nuclides,
gamma ray, x-ray,
neutron
All cancer 3.9 million
person-years
Zielinski JM,
Garner MJ52
2009 5 5 67,582 Cohort Canadian medical
workers
Medical x-rays Cancer
mortality &
incidence
36 years
Ronckers CM,
Doody MM53
2008 6 3 3,010 Cohort US scoliosis female X-ray Breast Cancer 118,905 total
years, median
35.5 years
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Cardis E,
Vrijheid M54
2007 7 6 407,391 Cohort 15 country nuclear
workers
Radio-nuclides,
gamma ray, x-ray,
neutron
All cancer
mortality (cause
specific)
5.2 million
person-years
Cardis E, Vrijheid M55 2005 7 3 407,391 Cohort 15 country nuclear
workers
Radio-nuclides,
gamma ray, x-ray,
neutron
All cancer
mortality
5.2 million
person-years
Matsuura M,
Hoshi M56
1997 7 6 35,123 Cohort Hiroshima
prefecture atomic
bomb survivors
Atomic bomb
radiation
All cancer
mortality
646,209
person-years
Howe GR,
McLaughlin J57
1996 7 3 31,917 Cohort Canadian
Tuberculosis
Fluoroscopy (x-ray) Breast cancer
mortality
Mean 31 years
Cardis E, Gilbert ES58 1995 7 5 95,673 Cohort Nuclear workers
(US, Canada, UK)
Radio-nuclides,
gamma ray, x-ray,
neutron
All cancer
mortality
2,124,526
person-years
Hoffman DA,
Lonstein JE59
1989 6 5 1,030 Cohort US scoliosis
patients
X-ray Breast cancer Mean 26 years
NIH Quality Assessment Score for Meta-Analyses
Jansen-Van Der
Weide, MC60
2010 5 out of 8
possible criteria
2 7 studies;30 to
5865 subjects
Meta-analysis Womenwith genetic
risk for breast
cancer
Diagnostic medical
x-rays
Breast cancer Not stated to
20 years
ARTICLES NOT SUPPORTING CANCER INDUCTION BY LOW-DOSE RADIATION
Authors Year Total NOS
Score
Low-Quality
Indicator
Score
Sample Size Study Design Exposed
Population
Radiation Source Outcome
Measures
Follow-Up
Length
Ohira T,
Takahashi H61
2016 4 4 300,476 Cross sectional Persons age 0–18
living in Fukushima,
Japan
External gamma
radiation
Thyroid cancer 4 years
Lee T, Sigurdson AJ62 2015 6 4 65,719 Cohort US radiologic
technologists
Diagnostic medical
x-rays
Basal cell
carcinoma
55 years
White IK, Shaikh KA63 2014 6 1 104 Cohort Children requiring
CSF shunts
Head CT scans Any cancer 10 years
Metz-Flamant C,
Laurent O64
2013 8 5 59,021 Cohort French nuclear
workers
Neutrons, x-rays,
and gamma rays
Any cancer,
stroke, or CAD
36 years
Pogoda, JM, Nichols,
PW65
2011 6 3 412 Case control Adults living in Los
Angeles
Diagnostic medical
x-rays
Acute myeloid
leukemia
7 years
Yuan, M-K,
Chien, C-W66
2010 3 3 2,292 Case control Cardiologists in
Taipei, Taiwan
Radiation from
fluoroscopy
Cancer,
number of
medical visits,
cataracts, URIs
4 years
Vrijheid M,
Cardis E67
2008 6 2 295,963 Cohort Nuclear workers in
15 countries
X-rays and gamma
rays
Chronic
lymphocytic
leukemia
deaths
4.5 million
person-years;
13-year
average
Schultz © 2020 Prehospital and Disaster Medicine
Table 3. Articles with Lower Quality Methodologies Characterized by Supporting or Not Supporting Cancer Induction by Low-Dose Radiation (continued)
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ARTICLES SUPPORTING CANCER INDUCTION BY LOW-DOSE RADIATION
Authors Year Total NOS
Score
Low-Quality
Indicator
Score
Sample Size Study
Design
Exposed
Population
Radiation Source Outcome
Measures
Follow-Up
Length
Lambe M, Hall P68 2005 6 2 23,097 Cohort Sweden patients
getting PTCA
Fluoroscopy All cancer
incidence
10 years
Zielinski JM, Garner
MJ69
2005 5 2 42,175 Cohort Canadian dental
workers
Diagnostic dental x-
rays
Cancer
mortality &
incidence
36 years
Engels H,
Swaen GM70
2005 8 3 7,229 Cohort Nuclear workers in
Belgium
Neutrons, gamma
rays
All cause and
cancer mortality
25 years
Langner I, Blettner M71 2004 6 1 19,184 Cohort European male
airline cockpit crew
members
Cosmic gamma
radiation
All cause and
cancer mortality
336,000
person- years;
36 years
Iwasaki T, Murata M72 2003 6 1 176,000 Cohort Male nuclear
workers in Japan
Gamma radiation All cause and
cancer mortality
10 years
Artalejo FR, Lara SC73 1997 6 1 5,657 Cohort Spanish nuclear
workers and miners
Gamma radiation All cause and
cancer mortality
38 years
Jablon S, Boice JD74 1993 5 2 9,132 Cohort Workers at a US
nuclear power plant
Gamma radiation All cause and
cancer mortality
20 years
Schultz © 2020 Prehospital and Disaster Medicine
Table 3. (continued). Articles with Lower Quality Methodologies Characterized by Supporting or Not Supporting Cancer Induction by Low-Dose Radiation
Abbreviations: CAD, Coronary Artery Disease; CSF, Cerebral Spinal Fluid; CT, Computed Tomography; NOS, Newcastle Ottawa Scale; PTCA, Percutaneous Transluminal Coronary
Angioplasty; UK, United Kingdom; URI, Upper Respiratory Infection; US, United States.
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